These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

308 related articles for article (PubMed ID: 36156920)

  • 1. Prevalence and factors associated with vitamin C deficiency in inflammatory bowel disease.
    Gordon BL; Galati JS; Yang S; Longman RS; Lukin D; Scherl EJ; Battat R
    World J Gastroenterol; 2022 Sep; 28(33):4834-4845. PubMed ID: 36156920
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Leucine-Rich Alpha-2 Glycoprotein Is a Reliable Serum Biomarker for Evaluating Clinical and Endoscopic Disease Activity in Inflammatory Bowel Disease.
    Shimoyama T; Yamamoto T; Yoshiyama S; Nishikawa R; Umegae S
    Inflamm Bowel Dis; 2023 Sep; 29(9):1399-1408. PubMed ID: 36334015
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of Vitamin D Deficiency on Inflammatory Markers and Clinical Disease Activity in IBD Patients.
    López-Muñoz P; Beltrán B; Sáez-González E; Alba A; Nos P; Iborra M
    Nutrients; 2019 May; 11(5):. PubMed ID: 31083541
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Altered fecal bile acid composition in active ulcerative colitis.
    Sommersberger S; Gunawan S; Elger T; Fererberger T; Loibl J; Huss M; Kandulski A; Krautbauer S; Müller M; Liebisch G; Buechler C; Tews HC
    Lipids Health Dis; 2023 Nov; 22(1):199. PubMed ID: 37980492
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fatigue is not associated with vitamin D deficiency in inflammatory bowel disease patients.
    Frigstad SO; Høivik ML; Jahnsen J; Cvancarova M; Grimstad T; Berset IP; Huppertz-Hauss G; Hovde Ø; Bernklev T; Moum B; Jelsness-Jørgensen LP
    World J Gastroenterol; 2018 Aug; 24(29):3293-3301. PubMed ID: 30090009
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of Serum Calprotectin Levels in Patients with Inflammatory Bowel Disease.
    Mori A; Mitsuyama K; Sakemi R; Yoshioka S; Fukunaga S; Kuwaki K; Yamauchi R; Araki T; Yoshimura T; Yamasaki H; Tsuruta K; Morita T; Yamasaki S; Tsuruta O; Torimura T
    Kurume Med J; 2021 Dec; 66(4):209-215. PubMed ID: 34690210
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vitamin D deficiency in outpatients with inflammatory bowel disease: prevalence and association with clinical-biological activity.
    Olmedo Martín RV; González Molero I; Olveira Fuster G; Amo Trillo V; Jiménez Pérez M
    Rev Esp Enferm Dig; 2019 Jan; 111(1):46-54. PubMed ID: 30284908
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neopterin is a novel reliable fecal marker as accurate as calprotectin for predicting endoscopic disease activity in patients with inflammatory bowel diseases.
    Nancey S; Boschetti G; Moussata D; Cotte E; Peyras J; Cuerq C; Haybrard J; Charlois AL; Mialon A; Chauvenet M; Stroeymeyt K; Kaiserlian D; Drai J; Flourié B
    Inflamm Bowel Dis; 2013 Apr; 19(5):1043-52. PubMed ID: 23511035
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Toronto IBD Global Endoscopic Reporting [TIGER] Score: A Single, Easy to Use Endoscopic Score for Both Crohn's Disease and Ulcerative Colitis Patients.
    Zittan E; Steinhart AH; Aran H; Milgrom R; Gralnek IM; Zelber-Sagi S; Silverberg MS
    J Crohns Colitis; 2022 May; 16(4):544-553. PubMed ID: 34272937
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Noninvasive markers in the assessment of intestinal inflammation in inflammatory bowel diseases: performance of fecal lactoferrin, calprotectin, and PMN-elastase, CRP, and clinical indices.
    Langhorst J; Elsenbruch S; Koelzer J; Rueffer A; Michalsen A; Dobos GJ
    Am J Gastroenterol; 2008 Jan; 103(1):162-9. PubMed ID: 17916108
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationship of clinical symptoms with biomarkers of inflammation in pediatric inflammatory bowel disease.
    Hoekman DR; Diederen K; Koot BG; Tabbers MM; Kindermann A; Benninga MA
    Eur J Pediatr; 2016 Oct; 175(10):1335-42. PubMed ID: 27573259
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multidimensional Impact of Mediterranean Diet on IBD Patients.
    Chicco F; Magrì S; Cingolani A; Paduano D; Pesenti M; Zara F; Tumbarello F; Urru E; Melis A; Casula L; Fantini MC; Usai P
    Inflamm Bowel Dis; 2021 Jan; 27(1):1-9. PubMed ID: 32440680
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Prevalence of Iron and Vitamin D Deficiencies in Pediatric Patients With Inflammatory Bowel Disease in Bahrain.
    Isa HM; Alahmed FA; Mohamed M; Mohamed A
    Cureus; 2023 Apr; 15(4):e37074. PubMed ID: 37143618
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Faecal Myeloperoxidase as a Biomarker of Endoscopic Activity in Inflammatory Bowel Disease.
    Swaminathan A; Borichevsky GM; Edwards TS; Hirschfeld E; Mules TC; Frampton CMA; Day AS; Hampton MB; Kettle AJ; Gearry RB
    J Crohns Colitis; 2022 Dec; 16(12):1862-1873. PubMed ID: 35803583
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predictors of vitamin D deficiency in inflammatory bowel disease and health: A Mississippi perspective.
    Pallav K; Riche D; May WL; Sanchez P; Gupta NK
    World J Gastroenterol; 2017 Jan; 23(4):638-645. PubMed ID: 28216970
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fecal calprotectin and its correlation with inflammatory markers and endoscopy in patients from India with inflammatory bowel disease.
    Samant H; Desai D; Abraham P; Joshi A; Gupta T; Dherai A; Ashavaid T
    Indian J Gastroenterol; 2015 Nov; 34(6):431-5. PubMed ID: 26589229
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Factors affecting vitamin D deficiency in active inflammatory bowel diseases.
    Burrelli Scotti G; Afferri MT; De Carolis A; Vaiarello V; Fassino V; Ferrone F; Minisola S; Nieddu L; Vernia P
    Dig Liver Dis; 2019 May; 51(5):657-662. PubMed ID: 30587439
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vitamin D deficiency in patients with inflammatory bowel disease: association with disease activity and quality of life.
    Ulitsky A; Ananthakrishnan AN; Naik A; Skaros S; Zadvornova Y; Binion DG; Issa M
    JPEN J Parenter Enteral Nutr; 2011 May; 35(3):308-16. PubMed ID: 21527593
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum 25-hydroxyvitamin D concentration and inflammatory bowel disease characteristics in Romania.
    Dumitrescu G; Mihai C; Dranga M; Prelipcean CC
    World J Gastroenterol; 2014 Mar; 20(9):2392-6. PubMed ID: 24605037
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TWEAK is not elevated in patients with newly diagnosed inflammatory bowel disease.
    Grimstad T; Skoie IM; Doerner J; Isaksen K; Karlsen L; Aabakken L; Omdal R; Putterman C
    Scand J Gastroenterol; 2017 Apr; 52(4):420-424. PubMed ID: 28040992
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.